Cargando…
Contribution of dynamic sentinel lymphoscintigraphy images to the diagnosis of patients with malignant skin neoplasms in the upper and lower extremities
The aim of the present study was to confirm the contribution of dynamic images in sentinel lymphoscintigraphy in malignant skin neoplasms: precisely, to investigate if dynamic images were necessary and to observe if dynamic images could reduce the areas needed for biopsy and dissection. Twenty-five...
Autores principales: | Miura, Hiroyuki, Ono, Shuichi, Shibutani, Koichi, Seino, Hiroko, Tsushima, Fumiyasu, Kakehata, Shinya, Hirose, Katsumi, Fujita, Hiromasa, Kakuta, Akihisa, Aoki, Masahiko, Hatayma, Yoshiomi, Kawaguchi, Hideo, Sato, Mariko, Takai, Yoshihiro, Kaneko, Takahide, Sawamura, Daisuke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4221556/ https://www.ncbi.nlm.nih.gov/pubmed/25392795 http://dx.doi.org/10.1186/2193-1801-3-625 |
Ejemplares similares
-
Impact of pretreatment whole-tumor perfusion computed tomography and (18)F-fluorodeoxyglucose positron emission tomography/computed tomography measurements on local control of non–small cell lung cancer treated with stereotactic body radiotherapy
por: Aoki, Masahiko, et al.
Publicado: (2016) -
Clinical outcome of stereotactic body radiotherapy for primary and oligometastatic lung tumors: a single institutional study with almost uniform dose with different five treatment schedules
por: Aoki, Masahiko, et al.
Publicado: (2016) -
Stereotactic body radiotherapy for lung metastases as oligo-recurrence: a single institutional study
por: Aoki, Masahiko, et al.
Publicado: (2016) -
Correlation between tumor size and blood volume in lung tumors: a prospective study on dual-energy gemstone spectral CT imaging
por: Aoki, Masahiko, et al.
Publicado: (2014) -
Radiation-induced rib fracture after stereotactic body radiotherapy with a total dose of 54–56 Gy given in 9–7 fractions for patients with peripheral lung tumor: impact of maximum dose and fraction size
por: Aoki, Masahiko, et al.
Publicado: (2015)